Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült KirályságFázis nélkül

Breath Research Narrow Validation for Gastrointestinal Cancer Detection

A legfontosabb adatok

Ki végzi
Imperial College London
Hol
Glasgow, Liverpool, London és Maidstone (Egyesült Királyság)Mind a 6 helyszín megnézése
Azonosító
Állapot
Toboroz
Résztvevők
1000 fő, tervezett
Kezdés
2026. júl. 26.
Várható befejezés
2029. febr. 2.
A vizsgálat típusa
Megfigyeléses, 5 csoport
A regiszteradat frissítve
2026. október 22.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

A vizsgálat olyan felnőtteket keres, akiknek emésztőrendszeri daganata van, valamint olyan felnőtteket, akiknek nincs daganatuk, de homályos hasi panaszaik vannak. Mindenki légmintát ad egy daganatot kereső lélegzetteszt kipróbálásához.

Életkor
18 éves vagy idősebb
Nem
Mindkét nemű és minden nemű személy részt vehet
A betegség stádiuma
Szövettanilag igazolt emésztőrendszeri daganat (vastag- vagy végbél, hasnyálmirigy, nyelőcső, gyomor), vagy szövettani vagy képalkotó vizsgálattal igazolt májdaganat. A daganat nélküli résztvevőknek homályos hasi panaszaik vannak, és a vizsgálati leleteik normálisak vagy jóindulatúak.
Korábbi kezelés
Aki a daganata miatt már kapott kemoterápiát, sugárkezelést vagy műtétet, nem vehet részt.

A részvétel fő kizáró okai

  • A daganat miatt már volt kemoterápiája, sugárkezelése vagy műtétje
  • Az elmúlt három évben másik daganata volt (a melanómától eltérő bőrdaganat nem számít)
  • Olyan egészségi probléma, amely akadályozza a légminta levételét
  • Nem tud vagy nem akar beleegyező nyilatkozatot adni
  • Allergia a tápláló italra (csak a nyelőcső- és gyomorcsoportban)

A regiszter feltételei, szó szerint

Mind a 18 feltétel megnézéseKevesebb

Ki vehet részt

  • Adult participants ≥ 18 years old who meet at least one of the following criteria
  • Colorectal arm:
  • Cancer: Histologically-confirmed CRC*
  • Control: Non-specific abdominal symptoms with normal or benign colonoscopy findings; Pancreatic arm:
  • Cancer: Histologically-confirmed PDAC*
  • Control: Non-specific abdominal symptoms with a radiologically-normal pancreas; Oesophagogastric arm:
  • Cancer: Histologically-confirmed OGC*
  • Control: Non-specific abdominal symptoms with normal or benign upper gastrointestinal endoscopy findings; Oesophageal squamous arm:
  • Cancer: Histologically-confirmed OSCC*
  • Control: Non-specific abdominal symptoms with normal or benign upper gastrointestinal endoscopy findings; Liver arm:
  • Cancer: Histologically- or radiologically-confirmed HCC or CCC*
  • Control: Non-specific abdominal symptoms with a radiologically-normal liver; Patients with suspected cancer (e.g. based on imaging) but who do not have histological confirmation prior to participating in the study may still be recruited and followed up to determine whether or not a diagnosis of cancer was subsequently confirmed

Ki nem vehet részt

  • Patients who have already received chemotherapy, radiotherapy or surgery for their cancer
  • (For Colorectal arm only): Participants receiving bowel prep in the previous 7 days
  • History of another cancer (other than non-melanoma skin cancers) within three years
  • (For Oesophagogastric arm only): Allergies to any of the constituents of the nutrient drink including glucose, glycerol, iron sulphate, Maltodextrin (Corn, Potato), Xanthan Gum, Potassium Chloride, tyrosine, phenylalanine, and glutamic acid
  • Participants with co-morbidities preventing breath collection
  • Unable or unwilling to provide informed consent

Helyszínek itt: Egyesült Királyság

  • NHS Greater Glasgow and ClydeGlasgow, Egyesült KirályságContact: Gary Nicholson, MBBS; FRCSToborzás még nem indult
  • Liverpool University Hospitals NHS Foundation TrustLiverpool, Egyesült KirályságContact: Andrew Moore, MBBS; MRCPToborzás még nem indult
  • The Clatterbridge Cancer Centre NHS Foundation TrustLiverpool, Egyesült KirályságContact: Alia Alchawaf, MBBS; MRCPToborzás még nem indult
  • Imperial College Healthcare NHS TrustLondon, Egyesült KirályságContact: Jessie S McClymont, BScRésztvevőt keres
  • Royal Free London NHS Foundation TrustLondon, Egyesült KirályságContact: Georgia Woodfield, MBBS; MRCPToborzás még nem indult
  • Maidstone and Tunbridge Wells NHS TrustMaidstone, Egyesült KirályságContact: Samantha Forner, MBBS; MRCPToborzás még nem indult

A vizsgálatról

Mit akar kideríteni a vizsgálat

The investigators of this study are developing a simple breath test to help detect gastrointestinal (gut) cancers earlier, including cancers of the oesophagus (food pipe), stomach, pancreas, liver and bowel. These cancers often cause non-specific symptoms that are similar to benign conditions, making early diagnosis difficult. Delays between the onset of symptoms and referral for a diagnostic test such as an endoscopy or a scan, can allow the cancer to progress.

A teljes eredeti leírásKevesebb

The breath test detects small molecules called volatile organic compounds (VOCs) that are released in exhaled breath. Some of these VOCs are strongly associated with these cancers and may help identify high-risk patients who require urgent investigation.

In practice, patients who come to their GP with concerning symptoms will be offered the breath test. If the test is positive, patients can be referred promptly for a diagnostic test, while those with a negative result can be reassured and offered re-testing if symptoms persist. Earlier diagnosis could improve access to curative treatment while reducing unnecessary invasive investigations.

Previous studies have identified a panel of VOCs that appear to distinguish patients with gastrointestinal cancers from those without cancer. This study aims to confirm these findings in a new group of participants to determine whether the same biomarkers can be reliably identified.

Participants will provide a breath sample, usually before a hospital procedure they are already scheduled to undergo, and complete a short questionnaire about their medical history and medications. Some participants will also be asked to drink a nutritional supplement before providing a second breath sample. The results will help determine whether the breath test is reliable enough for further clinical evaluation

A vizsgálat 5 csoportja

  • Oesophagogastric Arm

    Cases will be patients with histology-confirmed, treatment naïve oesophageal (OAC) or gastric adenocarcinoma (GAC) and controls will be patients who have a normal upper GI tract or benign condition as diagnosed on the reference test (upper GI endoscopy). All eligible patients will be invited to participate. Participants will attend a one off research visit, after having fasted for 6 hours (water permitted) and sign a consent form. They will rinse their mouth with water, provide a baseline breath sample and consume an oral stimulant drink (a nutrient supplement). A further breath sample will be collected after 15 minutes, and an additional environment sample will also be collected. Participants will answer questions about their medical and drug history.

  • Oesophageal SCC Arm

    Cases will be patients with histology-confirmed, treatment naive Oesophageal Squamous Cell Carcinoma (OSCC) and controls will be patients who have a normal upper GI tract or benign condition as diagnosed on the reference test (upper GI endoscopy). All eligible patients will be invited to participate. Participants will attend a one-off research visit, after having fasted for 6 hours (water permitted) and sign a consent form. They will rinse their mouth with water and provide a breath sample. An additional environment sample will also be collected. Participants will answer questions about their medical and drug history.

  • Pancreatic Arm

    Cases will be patients with histology-confirmed, treatment naïve pancreatic ductal adenocarcinoma (PDAC) and controls will be patients with non-specific abdominal symptoms and a radiologically-normal pancreas as diagnosed on the reference test (ultrasound, MRI, CT, PET-CT and endoscopic ultrasound). All eligible patients will be invited to participate. Participants will attend a one-off research visit, after having fasted for 6 hours (water permitted) and sign a consent form. They will rinse their mouth with water and provide a breath sample. An additional environment sample will also be collected. Participants will answer questions about their medical and drug history.

  • Liver Arm

    Cases will be patients with histology-confirmed, treatment naïve hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCC) and controls will be patients with non-specific abdominal symptoms with a radiologically-normal liver as diagnosed on the reference test (ultrasound, MRI, CT and PET-CT). All eligible patients will be invited to participate. Participants will attend a one-off research visit, after having fasted for 6 hours (water permitted) and sign a consent form. They will rinse their mouth with water and provide a breath sample. An additional environment sample will also be collected. Participants will answer questions about their medical and drug history.

  • Colorectal Arm

    Cases will be patients with histology-confirmed, treatment naïve colorectal adenocarcinoma (CRC) and controls will be patients with non-specific abdominal symptoms with a normal lower GI tract or benign condition of the colon as diagnosed on the reference test (colonoscopy). All eligible patients will be invited to participate. Participants will attend a one-off research visit, after having fasted for 6 hours (water permitted) and sign a consent form. They will rinse their mouth with water and provide a breath sample. An additional environment sample will also be collected. Participants will answer questions about their medical and drug history.

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 12.
A regiszteradat frissítve
2026. október 22.